Syventosp. z o.o.Active

SyVento BioTech at BIO 2026: Building Partnerships That Accelerate Innovation

BIO International Convention 2026 brings together the global biotechnology community to explore new scientific breakthroughs, strategic partnerships, and opportunities that shape the future of healthcare. This year, SyVento BioTech will join industry leaders in San Diego to connect with biotech innovators, pharmaceutical companies, investors, and technology partners seeking to accelerate the development and commercialization of […]

SyVento BioTech Joins DefenceTech Cluster Initiative at the Horizon of Security Congress

Kielce, Poland – June 2026 SyVento BioTech has joined a group of leading organizations from industry, academia, technology, and critical infrastructure sectors in launching the DefenceTech Cluster / Horizon of Security initiative (Horyzont Bezpieczeństwa). The project aims to strengthen Poland’s technological resilience, strategic autonomy, and innovation capabilities through cross-sector collaboration. The initiative was presented during […]

Meet SyVento BioTech at BIO 2026 | Booth #4402

We are excited to announce that SyVento BioTech will be exhibiting at the BIO International Convention 2026, taking place June 22–25 in San Diego. As the largest and most comprehensive global biotech event, BIO brings together 20,000+ industry leaders from across the ecosystem, including biotech innovators, pharma companies, and policymakers. It is where partnerships are […]

SyVento BioTech signs an agreement with Nanosanquis to support the development and production of NanOX 4 Kidney fluid

SyVento BioTech is pleased to announce the planned collaboration with NanoSanguis S.A. on the implementation of the project “𝗡𝗮𝗻𝗢𝗫 𝟰 𝗞𝗶𝗱𝗻𝗲𝘆 – 𝗮 𝗻𝗲𝘅𝘁-𝗴𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝗼𝗻 𝗸𝗶𝗱𝗻𝗲𝘆 𝗽𝗲𝗿𝗳𝘂𝘀𝗶𝗼𝗻 𝗳𝗹𝘂𝗶𝗱 𝗯𝗮𝘀𝗲𝗱 𝗼𝗻 𝗮 𝘀𝘆𝗻𝘁𝗵𝗲𝘁𝗶𝗰 𝗼𝘅𝘆𝗴𝗲𝗻 𝗰𝗮𝗿𝗿𝗶𝗲𝗿.” Under the anticipated agreement, SyVento will provide comprehensive technological and analytical support for the development and manufacturing process of a Class III […]

SyVento BioTech officially obtains the Certificate of GMP Compliance of a Manufacturer

We are proud to announce that on 28 April 2026, SyVento BioTech officially received the Certificate of GMP Compliance of a Manufacturer, marking one of the most significant milestones in the company’s history. The certificate was granted following an inspection conducted under the national inspection programme, in connection with manufacturing authorisation no. 285/0662/25, and carried […]

SyVento BioTech is proud to be part of UK Biotech Day

SyVento BioTech is proud to be part of UK BioTech Day, a key meeting point for companies shaping the future of drug development, advanced therapies, and biotech commercialization. Our participation reflects SyVento BioTech’s focus on supporting biotech and pharmaceutical partners through expert regulatory, clinical, and commercial advisory services, from early development to market readiness. UK […]